372 related articles for article (PubMed ID: 32249970)
21. Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency.
Ritz S; Hahn D; Wami HT; Tegelkamp K; Dobrindt U; Schnekenburger J
Microb Cell Fact; 2020 Dec; 19(1):221. PubMed ID: 33272255
[TBL] [Abstract][Full Text] [Related]
22. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.
Roberts KJ; Bannister CA; Schrem H
Pancreatology; 2019 Jan; 19(1):114-121. PubMed ID: 30385188
[TBL] [Abstract][Full Text] [Related]
23. The investigation and management of pancreatic exocrine insufficiency: A retrospective cohort study.
Shandro BM; Ritehnia J; Chen J; Nagarajah R; Poullis A
Clin Med (Lond); 2020 Nov; 20(6):535-540. PubMed ID: 33199316
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic Enzyme Replacement Therapy for Patients Diagnosed With Pancreaticobiliary Cancer: Validation of an Algorithm for Dose Escalation and Management.
Carnie LE; Farrell K; Barratt N; Abraham M; Gillespie L; Satyadas T; McNamara MG; Hubner RA; Geraghty J; Bibby N; Valle JW; Lamarca A
Pancreas; 2021 Oct; 50(9):1254-1259. PubMed ID: 34860808
[TBL] [Abstract][Full Text] [Related]
25. Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer.
Roeyen G; Berrevoet F; Borbath I; Geboes K; Peeters M; Topal B; Van Cutsem E; Van Laethem JL
ESMO Open; 2022 Feb; 7(1):100386. PubMed ID: 35124465
[TBL] [Abstract][Full Text] [Related]
26. Exocrine pancreatic insufficiency following esophagectomy.
Huddy JR; Macharg FM; Lawn AM; Preston SR
Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
[TBL] [Abstract][Full Text] [Related]
27. COMPARING THE ENZYME REPLACEMENT THERAPY COST IN POST PANCREATECTOMY PATIENTS DUE TO PANCREATIC TUMOR AND CHRONIC PANCREATITIS.
Fragoso AV; Pedroso MR; Herman P; Montagnini AL
Arq Gastroenterol; 2016; 53(2):94-7. PubMed ID: 27305415
[TBL] [Abstract][Full Text] [Related]
28. Glycemic Variability Assessment in Newly Treated Exocrine Pancreatic Insufficiency With Type 1 Diabetes.
Lewis DM; Shahid A
J Diabetes Sci Technol; 2024 Mar; 18(2):430-437. PubMed ID: 35787705
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness analysis of pancreatin minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis.
Morawski JH; Prüfert A; van Engen A; Foerster D; Sander-Struckmeier S; Małecka-Panas E; Pezzilli R
J Med Econ; 2012; 15 Suppl 1():15-25. PubMed ID: 23043594
[TBL] [Abstract][Full Text] [Related]
30. The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
Knop FK; Vilsbøll T; Lund A; Krarup T; Holst JJ; Hornum M
JOP; 2010 Sep; 11(5):489-91. PubMed ID: 20818126
[No Abstract] [Full Text] [Related]
31. The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI).
Ní Chonchubhair HM; Bashir Y; Dobson M; Ryan BM; Duggan SN; Conlon KC
Pancreatology; 2018 Jun; 18(4):379-385. PubMed ID: 29502987
[TBL] [Abstract][Full Text] [Related]
32. Pharmacotherapy of chronic pancreatitis in terms of current clinical recommendations.
Maev IV; Bideeva ТВ; Kucheryavyy YA; Andreev DN; Bueverov AO
Ter Arkh; 2018 Aug; 90(8):81-85. PubMed ID: 30701942
[TBL] [Abstract][Full Text] [Related]
33. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
Graff GR; McNamara J; Royall J; Caras S; Forssmann K
Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244
[TBL] [Abstract][Full Text] [Related]
34. Patient-reported use of pancreatic enzyme replacement treatment (PERT) in pancreatic cancer in New Zealand and Australia: a cross-sectional survey study.
Landers A; Brown H; Al Ruheili J; Russell K; McKenzie C; Agar MR; Yenson VM; Clarke K; Windsor J
Support Care Cancer; 2024 Jun; 32(6):402. PubMed ID: 38831230
[TBL] [Abstract][Full Text] [Related]
35. Correlates of Pancreatic Enzyme Replacement Therapy Intake in Adults with Cystic Fibrosis: Results of a Cross-Sectional Study.
Olsen MF; Kjøller-Svarre MS; Møller G; Katzenstein TL; Nielsen BU; Pressler T; Lewis JI; Mathiesen IH; Mølgaard C; Faurholt-Jepsen D
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405943
[TBL] [Abstract][Full Text] [Related]
36. Less common etiologies of exocrine pancreatic insufficiency.
Singh VK; Haupt ME; Geller DE; Hall JA; Quintana Diez PM
World J Gastroenterol; 2017 Oct; 23(39):7059-7076. PubMed ID: 29093615
[TBL] [Abstract][Full Text] [Related]
37. [DELAYED RESULTS OF ENZYME REPLACEMENT THERAPY, PRESCRIBED BY RESULTS OF 13C-TRIGLYCERIDE BREATH TEST].
Chernyavskiy VV; Gvozdetska LS
Lik Sprava; 2015; (3-4):94-9. PubMed ID: 26827447
[TBL] [Abstract][Full Text] [Related]
38. Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: a Dutch national survey.
Sikkens EC; Cahen DL; van Eijck C; Kuipers EJ; Bruno MJ
Pancreatology; 2012; 12(1):71-3. PubMed ID: 22487479
[TBL] [Abstract][Full Text] [Related]
39. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy.
Roberts KJ; Schrem H; Hodson J; Angelico R; Dasari BVM; Coldham CA; Marudanayagam R; Sutcliffe RP; Muiesan P; Isaac J; Mirza DF
HPB (Oxford); 2017 Oct; 19(10):859-867. PubMed ID: 28711377
[TBL] [Abstract][Full Text] [Related]
40. Study of the gastrointestinal bioavailability of a pancreatic extract product (Zenpep) in chronic pancreatitis patients with exocrine pancreatic insufficiency.
Lieb JG; Patel D; Karnik N; Toskes PP
Pancreatology; 2020 Sep; 20(6):1092-1102. PubMed ID: 32800653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
